Predictions from the OncoNPC model could enable doctors to choose targeted treatments for difficult-to-treat tumors.

In addition to turning on genes involved in cell defense, the STING protein also acts as an ion channel, allowing it to control a wide variety of immune responses.

The new device, which can be incorporated into a bra, could allow more frequent monitoring of patients at high risk for breast cancer.

MIT researchers find timing and dosage of DNA-damaging drugs are key to whether a cancer cell dies or enters senescence.

Ultrasound research specialist and 2023 MIT Excellence Award winner Nicole Henning adapts ultrasound technology for more sensitive, less invasive imaging for disease modeling.

The device detects the same molecules that cell receptors do, and may enable routine early screening for cancers and other diseases.

The new strategy may enable engineered T cells to eradicate solid tumors such as glioblastoma.

With the new method, scientists can explore many cancer mutations whose roles are unknown, helping them develop new drugs that target those mutations.

Using this approach, researchers hope to deliver therapeutic RNA molecules selectively to cancer cells or other target cells.

A new study reveals that lymph nodes near the lungs create an environment that weakens T-cell responses to tumors.